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A B S T R A C T
It has been postulated that dihydroxyphenylacetic acid (DOPAC), a major dopamine metabolite, and
nitric oxide (NO) induce mitochondrial dysfunction in a synergistic manner. We examined the
combined effects of NO and DOPAC on PC-12 cells in terms of cell viability, nuclear morphology,
mitochondrial parameters and cell death mechanisms. The apoptotic cell death induced by the NO-
donor, S-nitroso-N-acetylpenicillamine (SNAP), was differently modulated by DOPAC as a function of
DOPAC/cell ratios. Whereas below 200 nmol/106 cells, DOPAC inhibited a typical apoptotic pathway
induced by exposure the cells to the NOdonor, above 200 nmol DOPAC/106 cells, the cell deathwas not
only enhanced but encompassed a distinct mechanism. Loading the cells with dopaminemimicked the
effects of DOPAC. Specifically, the combination of DOPAC and NO induced an early mitochondrial
membrane potential dissipation and ATP depletion followed by loss of cellular membrane integrity.
Mitochondrial dysfunction was accompanied by the release of cytochrome c in both cases, NO
individually and in combination with DOPAC, but caspase-3 and caspase-9 activation were only
observed in the absence of DOPAC. DOPAC alone was ineffective. Thus, our results suggest a role for
DOPAC as a modulator of cell fate and point to a pathway of cell death involving DOPAC and NO, via
mechanisms that include mitochondrial dysfunction but do not involve the activation of the typical
apoptotic caspase cascade. The significance of these results is discussed in connection with the
mechanisms of cell death underlying Parkinson’s disease.
 2008 Elsevier Inc. All rights reserved.
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NeuroToxicology1. Introduction
Parkinson’s disease is one of the most common neurodegen-
erative diseases that results primarily from the degeneration of
dopaminergic neurons in the substantia nigra pars compacta
(Bernheimer et al., 1973). Although the precise mechanisms
underlying the cell death in Parkinson’s disease are not clearly
established, several studies suggest that an excessive or inap-
propriate formation of nitric oxide (NO) (and its derivatives) may
modulate cell events that are involved in the neuronal death
pathways (Przedborski et al., 1996; Schulz et al., 1997; Dawson and
Dawson, 1998; Zhang et al., 2006).
The association of NO pathways with Parkinson’s disease is
strengthened by studies showing that induction of iNOS (inducible* Corresponding author. Tel.: +351 239 852561; fax: +351 239 852569.
E-mail address: laranjin@ci.uc.pt (J. Laranjinha).
Abbreviations: ATP, adenosine triphosphate; LDH, lactate dehydrogenase; MTT, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide; RH 123, rhodamine
123; SNAP, S-nitroso-N-acetylpenicillamine.
0161-813X/$ – see front matter  2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.neuro.2008.07.003nitric oxide synthase) in glial cells contributes to degeneration of
dopamine-containing neurons in a mice model of Parkinson’s
disease (Liberatore et al., 1999). Moreover, the inhibition of nNOS
(neuronal nitric oxide synthase) prevents Parkinsonism in animal
models of the disease (Schulz et al., 1995; Hantraye et al., 1996;
Przedborski et al., 1996; Dehmer et al., 2000; Klivenyi et al., 2000;
Watanabe et al., 2004, 2008).
On the other hand, the observation that cell death occurred
primarily in dopaminergic neurons has focused the attention on
the dopamine molecule itself and on an abnormal metabolism of
dopamine as a potential mediating factor. In fact, it was reported
that dopamine and its metabolites are able to induce toxicity in
dopaminergic cells via mechanisms that range from an oxidative
stress phenomenon (Fahn and Cohen, 1992; Rabinovic et al., 2000)
to specific modifications of critical proteins, such as the covalent
modification of parkin (LaVoie et al., 2005), triggering apoptotic
death in various neuronal cultures (Jones et al., 2000; Lamensdorf
et al., 2000a; Kristal et al., 2001; Lotharius et al., 2005;Mazzio et al.,
2004).
Although excessive NO production and dopamine or its meta-
bolites have been independently implicated in neurodegeneration,
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(Antunes et al., 2005). For instance, glutamate potentiates
simultaneously NO production and toxic effects of dopamine
towards neuronal cells (Garthwaite and Boulton, 1995). In turn,
NO regulates dopamine release in the hippocampus of rats
(Segieth et al., 2000;Wegener et al., 2000), affecting also dopamine
reuptake (Cook et al., 1996). Also, NO activates tyrosine
hydroxylase (the limiting-enzyme in the synthesis of dopamine)
(Roskoski and Roskoski, 1987) and mitochondrial damage by NO
is potentiated by dopamine in PC-12 cells (Antunes et al., 2002).
Moreover, Laranjinha and Cadenas (2002) reported the formation
of reactive intermediates from the interaction of NO with 3,4-
dihydroxyphenylacetic acid (DOPAC), a major metabolite of
dopamine. Later, it was demonstrated that DOPAC may act
synergistically with NO, leading to mitochondrial dysfunction
(Nunes et al., 2005). Therefore, mitochondrial dysfunction and
oxidative/nitrosative stress appear to coordinate pathways leading
to degeneration of dopaminergic neurons.
The present study entails an assessment of the toxic effects of
NO and DOPAC, independently and in combination, in rat
pheochromocytoma-derived PC-12 cells.
Whereas below 200 nmol/106 cells, DOPAC protects the cells
from NO-mediated death, when combined with NO above
200 nmol DOPAC/106 cells, induced an enhanced cell death, invol-
ving mitochondrial dysfunction, that is mechanistically distinct
from that induced by NO as it does not involve caspases activation.
2. Materials and methods
2.1. Chemicals and biochemicals
DOPAC was purchased from Fluka Chemie (Neu-Ulm, Switzer-
land). SNAP was obtained fromWPI (Sarasota, FL, USA). RPMI 1640
cell culture medium was from Sigma Chemicals Co. (St. Louis, MO,
USA); fetal bovine serum (FBS) and phosphate-buffered saline
(PBS) pH 7.4 were purchased from Gibco-Invitrogen. General
laboratory chemicals as well as poly-lysine, MTT and Hoechst
33258 were from Sigma Chemicals Co. (St. Louis, MO, USA).
DOPAC solution was prepared in ultra pure water (obtained
from a Milli-Q system, Millipore Company, Bedford, MA, USA)
previously saturated with argon. This solution was prepared every
day and used freshly.
To measure the concentration of NO generated by the NO
donor S-nitroso-N-acetylpenicillamine (SNAP) we used the ISO-NO
Mark II nitric oxide meter and sensor fromWPI (Sarasota, FL, USA).
2.2. Cell culture
The rat pheochromocytoma cell line PC-12, purchased from
ECACC (European Collection of Cell Cultures), was routinely grown
in RPMI 1640 medium without antibiotics supplemented with
heat-inactivated fetal bovine serum (FBS) (10%, v/v) onto 75 cm2
flasks and maintained at 37 8C, in a humidified atmosphere of 5%
CO2. Cells were plated (5  104 cells cm2) 24 h before experi-
ments. The medium was always replaced by fresh medium before
treatments of the cells.
2.3. Analysis of cell viability
The cell viability was assessed by using the MTT assay, which is
based on the reduction of the dye MTT to formazan, an insoluble
intracellular blue product, by cellular dehydrogenases (Denizot
and Lang, 1986). Briefly, after incubation of the cells under the
specified conditions, the culture medium was removed, and the
cells washed twice with PBS. ThenMTTwas added to eachwell at afinal concentration of 0.5 mg/ml. Following incubation during 1 h
at 37 8C, MTT was removed and 1 ml of DMSO was added and
mixed thoroughly until formazan crystals were dissolved. The
mixture was then collected from each well and the extent of MTT
reduction was measured spectrophotometrically at 540 nm. Cell
viability was expressed as a percentage of the control cultures.
2.4. Evaluation of cell death
The plasma membrane integrity was assessed indirectly by
measuring the activity of the cytoplasmic enzyme lactate
dehydrogenase (LDH) in the extracellular medium. LDH activity
was spectrofluorimetrically evaluated in an auto analyzer Syn-
chron CX (Beckman Coulter) following the manufacturer’s
instructions. Results were expressed as percentage of total LDH
release. Total cellular LDH was determined after lysing the cells.
2.5. Assessment of cellular morphology
The cellular morphology was analysed with the May-Gru¨n-
wald-Giemsa staining. PC-12 cells were plated onto glass cover-
slips coated with poly-lysine. After incubation under the specified
conditions, the cellswerewashed twicewith PBS, fixedwith 4% (w/
v) paraformaldehyde in PBS (15 min), rinsed, and stained with a
May-Gru¨nwald solution for 5 min at room temperature. Then cells
were stained with Giemsa solution for 15 min at room tempera-
ture. Cells were rinsed with water. The stained cells were
visualized using a Zeiss Axiovert 40 CFL microscope equipped
with an AxiocamMRc camera. Only cells that remained attached to
the plates were observed.
2.6. Assessment of nuclear morphology
The nuclear morphology was analysed with Hoechst 33258, a
fluorescent dye that specifically labels nuclear DNA. PC-12 cells
were plated onto glass coverslips coated with poly-lysine. After
incubation under the specified conditions, the cells were washed
twice with PBS, fixed with 4% (w/v) paraformaldehyde in PBS
(15 min), rinsed, and stained with Hoechst 33258 (5 mg/ml) for
10 min at room temperature. The stained cells were visualized
using a Nikon fluorescence microscope employing a DAPI filter.
Only cells that remained attached to the plates were observed.
2.7. Measurement of cytochrome c release
The release of cytochrome c frommitochondria into the cytosol
was assessed by western blot. Briefly, following incubation under
the specified conditions, the cells were scraped and centrifuged at
500  g for 5 min. Then the cells were washed twice with PBS and
resuspended on lysis buffer, consisting of 75 mM NaCl, 1 mM
NaH2PO4, 8 mM Na2HPO4, 250 mM sucrose supplemented with
200mg digitonin/ml and 1:100 of a broad spectrum protease
inhibitor cocktail (Sigma Chemical Co.). After vigorous vortexing
this suspensionwas centrifuged at 14 000 rpm for 3 min at 48 C and
the supernant, corresponding to the cytosolic fraction, recovered.
Briefly, 25 mg of cytosolic protein extract was loaded onto each
lane of a SDS-polyacrylamide gel. The separated proteins were
electrotransferred to a polyvinylidene difluoride membrane
(Amersham Pharmacia Biotech, Buckinghamshire, UK). The mem-
branes were blocked for 2 h at room temperature with blocking
buffer (15 mMNaCl, 2.5 mM Tris–HCl, pH 7.6, and 0.1% Tween-20)
containing 5% non-fat drymilk. The blotswere then incubatedwith
primary mouse monoclonal antibody against the denatured form
of cytochrome c (1:1000, Pharmingen, San Diego, Ca, USA). The
membranes were then washed during 30 min and incubated with
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globulin (Ig) (1.15000, Abcam, Cambridge, UK), for 2 h at room
temperature. The bands were revealed with ECF (Amersham
Pharmacia Biotech, Buckinghamshire, UK) and visualised by using
a Versa-Doc Imaging System, model 3000 (BioRad, Hercules, CA,
USA). The images were analysed with the Quantity One software
(BioRad). b-Actin was used as a loading control. Protein concen-
trations were quantified by the BioRad protein assay dye, using
bovine serum albumin as the standard.
2.8. Measurement of caspase activity
Following the treatment with DOPAC, SNAP or DOPAC plus
SNAP, the cellswere harvested andwashed twice in PBS. Then, cells
were resuspended on a ice lysis buffer consisting of 1 mM Na-
ethylenediaminetetraacetic acid (Na-EDTA), 1 mM Na-ethylene
glycol-bis(b-aminoethylether)-N,N-tetraacetic acid (Na-EGTA),
2 mM MgCl26H2O, 25 mM HEPES (pH 7.5) supplemented with
0.1% CHAPS, 100mMphenylmethylsulfonyl fluoride (PMSF), 2 mM
DTT, and 1:100 of a broad spectrum protease inhibitor cocktail
(Sigma Chemical Co.). After freezing during three times in liquid
nitrogen, the cell extracts were centrifuged at 15 800  g for
10 min, at 4 8C and the supernatants were stored at 80 8C. To
measure caspase activity, aliquots of lysates containing 25mg of
protein were added to a reaction buffer (25 mM HEPES, pH 7.5)
supplementedwith 0.1% CHAPS, 5 mMDTT and 100 mMPMSF. The
reactions were initiated after addition of the following fluorimetric
substrates (50 mM final concentration): Ac-DEVD-Amc for cas-
pase-3-like activity, Ac-IETD-Amc for caspase-8-like activity and
Ac-LEDH-Afc for caspase-9-like activity. After 150 min of incuba-
tion at 37 8C the cleavage of the substrates was measured (Amc, l
excitation 390 nm and l emission 475 nm; Afc, l excitation
400 nm and l emission 505 nm). Caspases activity was expressed
as a percentage of the value in control cultures.
2.9. Determination of ATP levels
PC-12 cells were seeded onto 40 mm Petri dish. Following the
period of incubation, the medium was removed and the cells were
rinsed twice with PBS. Then ice-cold 0.3 M perchloric acid was
added and the cells were scraped, collected into Eppendorf tubes,
and centrifuged at 15,800  g, for 5 min at 4 8C. The pellets were
analysed for total protein content using the BioRad protein assay
kit. The supernatants were neutralized with 10 M KOH in 5 M Tris
and further centrifuged at 15,800  g, for 10 min at 4 8C to remove
the potassium perchlorate salt. The resulting supernatants were
assayed for adenosine triphosphate (ATP) using a reverse-phase
HPLC methodology, as described by Stocchi et al. (1985) The
chromatographic apparatus was a Beckman System Gold, consist-
ing of a 126 binary Pump Model and a 166 Variable UV detector
controlled by a computer. The columnwas a Lichrospher 100 RP-18
(5 mM) from Merck (Germany). An isocratic elution with 100 mM
KH2PO4 buffer at pH 6.5 with 1% methanol was performed at
flow rate of 0.9 ml/min. The adenine nucleotides were detected at
254 nm.
2.10. Fluorimetric analysis of mitochondrial membrane potential
Changes in mitochondrial membrane potential (Dcm) were
estimated using the fluorescent cationic dye rhodamine 123 (RH
123) as described by Palmeira et al. (1996). RH 123 accumulates
electrophoretically in mitochondria as a direct function of the
membrane potential and is released upon membrane depolariza-
tion. Cells were incubated at 37 8C, for 15 min, with 10 mM RH
123. Then the cells were washed three times with phosphatebuffer, centrifuged, resuspended in RPMI 1640 medium without
phenol red and transferred to a fluorometer cuvette. The fluor-
escence at excitation and emission wavelengths of 505 nm and
525 nm at 30 8C was recorded during 3 min using a PerkinElmer
LS-50B spectrofluorometer. Then FCCPwas added causing release
of rhodamine 123 and consequently an increase in fluorescence.
Results are expressed as a percentage of the dye retained within
control cells.
2.11. Immunocytochemistry
Following incubation under the specified conditions, the cells
were washed twice with PBS. Then, MitoTracker Deep Red
(mitochondria) was added to the culture to a final concentration
of 200 nM and incubated for 30 min. Afterwards, the cells were
washed twicewith PBS and fixedwith 4% paraformaldehyde in PBS
for 15 min at room temperature. After blocking and permeabiliza-
tion with PBS containing 0.1% saponin and 5% FBS for 30 min at
room temperature, cells were incubated with a mouse monoclonal
primary antibody anti-apoptotic-inducing factor (AIF) (1:100)
(Santa Cruz Biotech, Santa Cruz, USA) for 1 h at room temperature.
Cells were rinsed three times with PBS and then incubated with
Alexa fluor 488-conjugated secondary antibody (donkey anti-
mouse IgG, 1:1000) (Molecular Probes, Eugene, OR, USA). The
nuclei were stained with Hoechst 33258 (5 mg/ml) for 10 min at
room temperature. Cells were washed, mounted with Mowiol and
observed in a Zeiss Confocal microscope.
2.12. Statistical analysis
All data were expressed as mean  S.E.M. of at least three
independent assays, each one in duplicate. Significance between
groups was assessed by one-way analysis of variance (ANOVA). A
value of p lower than 0.05 was considered statistically significant.
3. Results
3.1. DOPAC modulation of NO-induced toxicity on PC-12 cells
PC-12 cells were treated with two concentrations (0.5 and
1 mM) of a NO donor, SNAP, and assayed for cytotoxicity after 1,
14 and 24 h incubation (Fig. 1). Typically, NO release from 1 mM
SNAP, in the presence of cells, reached a steady-state level between
0.8 and 1.3 mM after 1 h in RPMI 1640 medium. Moreover, it was
checked that completely decomposed SNAP had no effect on the
cell viability (not shown). Fig. 1 shows that SNAP reduced the
viability of PC-12 cells in a time- and concentration-dependent
manner. Indeed, whereas 0.5 mMSNAP induced a 19.6  3.3% and a
28.3  1.8% loss of cell viability, at 14 h and 24 h, respectively, 1 mM
SNAP induced a 34.9  1.1% and a 52.7  1.7% loss of cell viability for
identical time ranges (Fig. 1). At 1 h of incubation, the cell viability
was identical to the control.
Fig. 2 shows that the toxicity induced by SNAP is modulated by
DOPAC, being the final outcome affected by the concentration of
both compounds.When the cells are challengedwith 0.5 mMSNAP,
DOPAC at 200–400 nmol/106 cells are protective but 800 nmol/106
cells is devoided of an effect, being similar to 0.5 mM SNAP (Fig. 2a).
When 1 mM SNAP is used the cells are protected by 200 nmol
DOPAC/106 cells, but for higher DOPAC/cell ratios an increase in
toxicity is obvious (Fig. 2b). Furtherconsidering thatDOPACalone, at
the concentrations used,hadno significant effect on the cell viability
for the incubation times shown (datanot shown), the results suggest
that the cells are sensitive to DOPAC/NO concentration ratio, the
lower the concentration of NO, the higher the concentration of
DOPAC needed to stimulate toxicity.
Fig. 1. Evaluation of cell viability of PC-12 cells exposed to SNAP. Cells were plated
in 24 well plates containing 0.5 ml covered with poly-D-lysine at the density of
50  103 cells/cm2. After 24 h, the tissue culturemediawas replaced by freshmedia
and the cells were incubated with 0.5 mM SNAP or 1 mM SNAP as indicated in the
figure. Cell viability was measured at indicated times by determining the cellular
reducing capacity, by following the extent of MTT reduction, as described in Section
2. Data represent the mean  S.E.M. of at least six independent experiments in
triplicate and are expressed as percentage of control cells.
Fig. 2. Effect of DOPAC on SNAP-induced toxicity in PC-12 cells. Experimental
conditions were as described in Fig. 1. (a) Cells were incubated during 1, 14 and 24 h
with 0.5 mMSNAP, 200 nmol DOPAC/106 cells + 0.5 mMSNAP, 400 nmol DOPAC/106
cells + 0.5 mM SNAP and 800 nmol DOPAC/106 cells + 0.5 mM SNAP, as indicated in
figure. (b) The incubation’s conditions are as in part (a) except that the concentration
of SNAP was 1 mM. Data represent the mean S.E.M. of at least six independent
experiments in triplicate and are expressed as percentage of control cells.
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3.2.1. LDH leakage
The integrity of plasma membrane was evaluated as a feature
typical of necrosis, by measuring LDH leakage to the extracellular
medium induced by 800 nmol DOPAC/106 cells, 1 mM SNAP and
800 nmol DOPAC/106 cells in combination with 1 mM SNAP after
1 h, 4 h, 6 h, 8 h and 24 h of incubation. During the first 8 h of
incubation the membrane integrity of PC-12 cells incubated with
SNAP or DOPAC plus SNAP were not significantly affected
demonstrating that the cells were still viable (Fig. 3). It is of note
thatmembrane integrity is maintainedwhile loss of mitochondrial
potential and ATP loss is observed (Figs. 5 and 6 below).
However, as shown in Fig. 3, after 24 h of incubation with
DOPAC plus SNAP, a higher and significant increase of extracellular
LDH activity was observed (72.8  3.4), as compared with the cells
incubated with SNAP only (30  3.5). It is important to note that
DOPAC did not induce a significant LDH release into the extracellular
medium during 24 h (Fig. 3).
3.2.2. Cellular and nuclear morphology
Hallmarks of classic apoptosis include specific morphological
changes, such as cell shrinkage, blebbing, chromatin condensation,
nuclear fragmentation and loss of adhesion (Kerr et al., 1972). So, in
order to investigate the process of cell death induced by SNAP and
DOPAC plus SNAP, the cellular and nuclear morphology of cells
treated under the different experimental conditions were analysed
by using the May-Gru¨nwald-Giemsa dye and the fluorescent
nuclear dye Hoechst 33258, respectively (Fig. 4). Control cells
showed a round or spherical morphology with regular and round-
shaped nuclei (Fig. 4), whereas treated PC-12 cells manifested a
different morphology depending on the experimental conditions.
In cultures exposed to 1 mM SNAP, cells were round but some of
them showed the nuclei reduced in size and with an irregular
shape (Fig. 4). Few blebbing cells are also apparent (Fig. 4). DOPAC
plus SNAP-treated cells had a reduced volume when comparedFig. 3. Effect of co-added DOPAC and SNAP on the cell plasma membrane integrity.
The extent ofmembrane integrity was indirectly assessed bymeasuring the activity
of LDH in the extracellular medium. Cells were plated in 24 well plates containing
0.5 ml covered with poly-D-lysine at the density of 50  103 cells/cm2. After 24 h,
the tissue culture media was replaced by fresh media and the cells were incubated
during 1, 8 and 24 h with DOPAC (800 nmol/106 cells), SNAP (1 mM) or DOPAC plus
SNAP (nmol DOPAC/106 cells + 1 mM SNAP), as indicated in the figure. Then the
medium was collected and LDH leakage was expressed as LDH activity in the
medium as a percentage of total LDH activity. Data represent themean  S.E.M. of at
least four independent experiments. Statistical significance: $$$p < 0.001 as compared
to control cells; ***p < 0.001 as compared to cells incubated with 1 mM SNAP.
Fig. 4. Cellular and nuclear morphological analysis of PC-12 cells. Cells were grown in culture on coverslips for 24 h and then treated with DOPAC (800 nmol/106 cells), SNAP
(1 mM) or with the combination of both. After 14 h cells were fixed and stained as described in Section 2. Cell morphologywas examinedwith a Contrast of Phasemicroscope
(left panel) and the nuclear morphology was examined with a fluorescence microscope (right panel).
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condensed (Fig. 4), suggestive of an apoptotic-typemechanism and
not a necrotic cell death. Under both conditions, no fragmentation
was observed. Note that cells treated with 800 nmol DOPAC/106
cells (Fig. 4) did not exhibit noticeable modifications of nuclear
morphology relatively to the control cells (Fig. 4).
3.2.3. Mitochondrial membrane potential and ATP
Mitochondrial function is very sensitive to the presence of nitric
oxide (Brown, 1995; Borutaite and Brown, 1996; Lizasoain et al.,
1996; Giulivi, 1998; Brookes et al., 1999; Brown, 1999) and the
mechanism by which NO induces apoptosis in several cell types
appears to encompass changes in mitochondrial membrane
potential (Dcm) (Almeida et al., 2001; Bal-Price and Brown,
2000; Brorson et al., 1999; Solenski et al., 2003). To investigate the
alteration of Dcm in PC-12 cells treated with DOPAC, SNAP or
DOPAC plus SNAP, the fluorescent probe RH 123 was used as
described in Section 2. As shown in Fig. 5, after 1 h of incubation,
both, SNAP and DOPAC plus SNAP, induced a significant loss of
Dcm (72.95  1.2 and 60.75  2.14, respectively). The dissipation of
Dcm increased with time under both situations. However, the loss ofDcm was significantly stronger in the cells incubated with DOPAC
plus SNAP (Fig. 5). DOPAC had no effect on theDcm (data not shown).
Fig. 6 shows that incubation of cells with 1 mM SNAP or with
800 nmol DOPAC/106 cells plus 1 mMSNAP during 1 h resulted in a
similar and significant fall in ATP concentration as compared with
the control. However, whereas in the case of cells incubated with
1 mM SNAP, the initial fall in ATP concentration remained
unchanged along the incubation time, in the cells co-incubated
with DOPAC plus SNAP, ATP concentrations fell progressively over
the incubation period. We also evaluated lactate release to the
culturemedium as an index of glycolytic activity (data not shown).
In the cells incubated during 8 h with SNAP, but not in the cells co-
incubated with DOPAC plus SNAP, an increase in the lactate
production occurred (data not shown). Therefore, these results
indicate that DOPAC potentiates the NO-induced ATP depletion in
PC-12 cells. In cells incubated with DOPAC alone, we did not
observe any significant alteration of the ATP content (Fig. 6).
3.2.4. Cytochrome c release
A fall in the Dcm, may culminate in the release of several
proapototic factors from the mitochondrial intermembrane space
Fig. 5. Effect of SNAP and DOPAC plus SNAP on the mitochondrial membrane
potential of PC-12 cells. Cells were plated at a density of 50  103 cells/cm2 in
plastic Petri dishes coated with poly-D-lysine. Cells were incubated with DOPAC
(800 nmol/106 cells), SNAP (1 mM) or DOPAC plus SNAP and mitochondrial
membrane potential was measured at different time intervals as described in
Section 2. Mitochondrial membrane potential was expressed as the percentage of
the baseline values of RH 123 cellular retention in control cells, obtained by the
difference of fluorescence in the presence and in the absence of FCCP. Data are
expressed as the mean  S.E.M. derived from five independent experiments.
Statistical significance: $$$p < 0.001 as compared to control cells; ***p < 0.001 or
**p < 0.01 as compared to cells incubated with 1 mM SNAP.
Fig. 7. Immunoblot analysis of cytochrome c in the cytosolic fractions of PC-12 cells.
Cells were incubated with DOPAC (800 nmol/106 cells); SNAP (1 mM) or DOPAC
plus SNAP during 8 h. The cytosolic fractions were prepared as described in Section
2. Cytosolic proteins (25 mg) were subjected to immunoblot analysis using
cytochrome c antibodies and the resulting blots were quantified as described in
Section 2. $$$p < 0.001 or $$p < 0.01 as compared to control cells; ***p < 0.001 as
compared to cells incubated with 1 mM SNAP.
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investigated whether cytochrome c release occurred in the cells
incubated with SNAP or DOPAC plus SNAP. A western blot analysis
of cytosolic fractions derived from PC-12 cells showed that the
cytosolic content of cytochrome c increased significantly after 8 h
of incubationwith SNAP and DOPAC plus SNAP (Fig. 7), indicating a
release of cytochrome c from mitochondria. However, the concen-
tration of cytochrome c in cytosol was higher in cells incubated
with DOPAC plus SNAP (577  40%) as compared with SNAP alone
(277  67%). DOPAC itself did not induce a significant release of
cytochrome c when compared with control cells (Fig. 7).
3.2.5. Caspase activation
The release of cytochrome c from mitochondria can initiate
activation of apoptotic proteases, caspases, leading to cell death. ToFig. 6. Adenosine triphosphate (ATP) levels in PC-12 cells after exposure to SNAP or
DOPAC plus SNAP. Cells were plated at a density of 50  103 cells/cm2 in plastic
Petri dishes coated with poly-D-lysine. Cells were incubated with DOPAC
(800 nmol/106 cells), SNAP (1 mM) or DOPAC plus SNAP. Cellular ATP contents
weremeasured at indicated times by HPLC as described in Section 2. Data represent
the mean  S.E.M. of eight experiments in duplicate and are expressed as percentage
of control cells.examine whether the cell death induced by SNAP or DOPAC plus
SNAP is related to a pathway involving the activation of caspases,
we studied the time course of the activation of caspase-3-, 8- and
9-like proteases. Cytosolic fractions from PC-12 cells were exposed
to DOPAC, SNAP or DOPAC plus SNAP for different times (30 min,
2 h, 4 h, 6 h, 8 h, and 14 h) and tested for the cleaving activity of
three fluorogenic substrates (Ac-DEVD-Amc, Ac-IETD-Amc or Ac-
LEDH-Afc) as described under Section 2. As shown in Fig. 8a,
following 14 h treatment of PC-12 cells with 1 mM SNAP, we
detected a 1.5-fold increase of caspase-9-like activity as compared
with the control. Conversely, in PC-12 cells incubated with DOPAC
plus SNAP this caspasewas partially inactivated (Fig. 8a). Similarly,
caspase-3 showed a significant activation in cells treated 14 hwith
1 mM SNAP (1.6-fold the control value) (Fig. 8b) but no activation
of caspase-3-like activity was detected up to 14 h after treatment
with DOPAC plus SNAP (Fig. 8b).
Under both conditions of incubation, SNAP orDOPAC plus SNAP,
caspase-8-like activity was not significantly altered as compared
with the activity of untreated cells (data not shown). In cells
incubated with DOPAC, the basal activity of these three caspases
was similar to basal activity of control cells (data not shown).
To confirm these results, we assessed, with the MTT assay, the
cell viability after 24 h treatment with SNAP or DOPAC plus SNAP
in the presence of the z-VAD-fmk, which is widely used as a cell-
permeant caspase inhibitor in different experimental models,
including PC-12 cells (Fujita et al., 2006). 30 mM z-VAD-fmk
partially protected the cells incubatedwith 1 mM SNAP but had no
protective effect in the cell viability observed in the cells co-
incubated with DOPAC plus SNAP (data not shown).
Thus, the results suggest that, conversely to SNAP, DOPAC plus
SNAP does not induce a typical caspase-dependent process
apoptosis, but some alternative type of programmed cell death
that is caspase independent. Therefore, DOPAC, not only poten-
tiated NO-induced cell death, but also modifies the type of
programmed cell death induced by NO.
Fig. 8. Fluorimetric evaluation of caspase-9-like (a) and caspase-3-like (b) activities
in PC-12 cells exposed to SNAP and to DOPAC plus SNAP. Caspase activity was
measured after 0.5, 1, 2, 4, 6, 8 or 14 h incubation with DOPAC (800 nmol/106 cells),
SNAP (1 mM) or DOPAC plus SNAP. Substrate cleaving activity in control cells was
taken as 100%. Data represent the mean  S.E.M. of 8–12 experiments in duplicate.
Statistical significance: ***p < 0.001 or **p < 0.01 or *p < 0.05 as compared to control
cells.
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Because apoptotic-inducing factor is known to be involved in
the induction of apoptotic cell death via a caspase-independent
pathway, we next examined whether AIF plays a role in the
mechanisms underlying cell death induced by DOPAC plus SNAP
(Lorenzo et al., 1999; Susin et al., 1999; Loeffler et al., 2001). Cells
were incubated with DOPAC (800 nmol/106 cells), 1 mM SNAP or
DOPAC plus SNAP during 8 h, 14 h and 24 h and then submitted to
immunostaining, as indicated in Section 2, with an AIF antibody,
concurrently with the mitochondrial marker MitoTracker Deep
Red and Hoechst, a nuclear dye. Fig. 9 shows the results obtained
after 8 h of incubation and, apparently, the translocation of AIF to
the nucleus did not occur, suggesting that AIF is not mechan-
istically involved in the cell death induced by DOPAC plus SNAP.
4. Discussion
It has been shown that under conditions of excessive or
inappropriate formation NO and its derivatives may cause
neuronal cell death via mechanisms involving, among others,
mitochondrial dysfunction (Dawson and Dawson, 1998; Bolan˜os
et al., 1997; Brown, 1999).
We have previously shown that DOPAC, a major metabolic
product of dopamine, inhibits mitochondrial respiration synergis-
tically with NO in isolated brainmitochondria (Nunes et al., 2005).
Considering that this event could contribute to the mechanisms of
cell death observed during Parkinson’s disease, in the presentstudy, we demonstrated that DOPACmodulates the toxic effects of
NO in undifferentiated rat pheochromocytoma-derived PC-12
cells, a cell line widely used as a model for dopaminergic neurons
and known to synthesize, store, release and metabolize dopamine
in a manner analogous to that of cells in vivo in the mammalian
central nervous system (Greene and Tischler, 1976). The undiffer-
entiated PC-12 cells, while preserving dopamine metabolism, are
more sensitive to oxidative stress as compared with differentiated
cells (Ekshyyan and Aw, 2005).
Once ascertained the concentration of NO that caused a
significant decrease in cell viability (Fig. 1), we showed that DOPAC
affects cell survival in a way dependent on the concentration of
both, DOPAC and NO (Fig. 2). For 0.5 mMSNAP (corresponding to a
steady-state concentration of about 0.5 mM NO), DOPAC pre-
vented NO-dependent toxicity when present up to 800 nmol/106
cells in the medium (Fig. 2a). If the concentration of SNAP doubles
(corresponding to a steady-state concentration of about 1 mM
NO), 400–800 nmol DOPAC/106 cells acted synergistically with
NO to cause cell death (Fig. 2b).
That NO, depending on several conditions (e.g., flux of NO and
time of exposure) and factors (e.g. concentration of oxygen,
superoxide radical and thiols), may induce cell death via
programmed mechanisms or by necrosis, is extensively docu-
mented (Borutaite and Brown, 2005) in several cell types (Bal-Price
and Brown, 2000; Terwel et al., 2000; Yuyama et al., 2003). These
reports differ not only in the cell type studied but also in the
steady-state concentration of the NO, redox species involved and
the chemistry it undergoes in a given biological milieu. Under our
experimental conditions, both NO and the combined action of
DOPAC and NO induced a programmed cell death; only after 24 h
of incubation necrosis is significantly increased (Fig. 3). Moreover,
the results indicate that mitochondrial dysfunction is mechan-
istically involved in the death pathways induced by both, NO and
DOPAC plus NO because an early loss (1 h) ofDcm and a depletion
of ATP (Figs. 5 and 6, respectively)were observedwhen signs of cell
death were not apparent yet (Figs. 1–3). Preliminary results also
indicate that respiratory chain complexes were affected (data not
shown). Clearly, Figs. 5 and 6 show that DOPAC had no effect in the
Dcm and in the ATP levels, but it was able to potentiate the
NO-
induced Dcm decrease and ATP loss, thus acting synergistically
with NO in the potential induction of mitochondrial dysfunction.
These findings are in agreement with our previous work showing a
synergistic inhibition of respiration in isolated rat brain mitochon-
dria by NO and DOPAC (Nunes et al., 2005).
In fact, mitochondria is likely the preferential subcellular
setting for the interaction of DOPAC with NO, a statement that
may be understood in connection with several lines of evidence,
namely: (a) DOPAC synthesis occurs in the mitochondrial matrix
via the activity of an unspecific aldehyde dehydrogenase
(Ambroziak and Pietruszko, 1991; Keung and Vallee, 1998; Tank
et al., 1981); (b) the steady-state level of NO in the mitochondrial
matrix is expected to be particularly high (Boveris et al., 2000)
partially due to the activity of the mitochondrial nitric oxide
synthase (mtNOS) (Ghafourifar and Richter, 1997; Giulivi et al.,
1998) and also due to the diffusion of NO from other cellular
compartments and c) mitochondrial dysfunction seems to have a
major role in the pathogenesis of Parkinson’s disease (Mizuno
et al., 1998; Schapira et al., 1992).
Although, mitochondria is likely to play a center stage in the
mechanisms of NO and DOPAC plus NO toxicities, it appears that
DOPAC diverts cell death via a distinct programmed pathway. This
notion is supported by the observation that whereas, NO seems to
induce a classical apoptotic programmed cell death with release of
cytochrome c from mitochondria (Fig. 7), chromatin condensation
(Fig. 4) and activation of caspase-9 (Fig. 8a) and caspase-3 (Fig. 8b),
Fig. 9. Subcellular localization of AIF by immunocytochemistry. After treatment with DOPAC (800 nmol/106 cells), SNAP (1 mM) or with the combination of both for 8 h, the
cells were immunostained with an anti-AIF monoclonal antibody and counterstained with the mitochondria dye MitoTracker Deep Red and the nuclear dye Hoechst as
described under Section 2.
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c release (but in much higher extension than for SNAP alone)
(Fig. 7) and condensation of nucleus (Fig. 4) occurred in the
absence of caspases activation (Fig. 8a and b). In fact, several
studies suggest that in this neurodegenerative disease the neurons
can die by a caspase-independent cell death (Graeber et al., 1999;
Han et al., 2003; Chu et al., 2005; Liou et al., 2005).
In order to investigate the mechanisms underlying cell death
induced by DOPAC plus SNAP, we checked whether the apoptotic-
inducing factor (AIF), identified as a key player in the caspase-
independent cell death pathway (Lorenzo et al., 1999; Susin et al.,
1999; Loeffler et al., 2001) could be involved. AIF is a flavoprotein
that in normal conditions is confined to the mitochondrial
intermembrane space. In response to apoptogenic stimulus, AIF
translocates to the nucleus where it induces chromatin condensa-
tion and high molecular weight DNA fragmentation, as well as it
evokes dissipation of theDcm and exposure of phosphatidylserine
(Susin et al., 2000). However, immunofluorescence experiments
suggest that AIF did not translocate to the nucleus (Fig. 9). So, AIF is
not the molecule responsible for the cell death that occurs in cells
co-incubated with DOPAC and NO. Lysis of the cells occurred in a
late stage of cell death and constitutes probably a secondary
necrosis (Fig. 3). Preliminary results – not shown – also indicate
that calpains are not involved in the mechanisms of cell death.
Therefore, one may conclude that not only DOPAC potentiates
NO-induced cell death but also modifies the mechanisms of cell
death induced by NO. Considering that NO and DOPAC mayinteract yielding free radicals and other reactive species (REF), an
oxidative/nitrosative stress is likely to occur.
Given the experimental design used, in which the cells were
challenged with a NO donor and DOPAC, it is important to
ascertain that the effects observed are not irrelevant positive
results due to an artificial acute damage mediated by oxidation
products of DOPAC and NO chemically produced in the cell
incubationmedium. First, when cells are loaded with dopamine, in
order to increase intracellular DOPAC content, and subsequently
exposed to NO, the effects of DOPAC plus NO are mimicked in
terms of increased cell death (not shown). Likewise, glipizide
(100mM), an inhibitor of DOPAC transport, in the presence of NO
donor, also potentiated cell death (not shown). These experimental
designs were however less reproducible as compared with the
situationwhen cells were directly challengedwith DOPAC. Second,
even when the cells were incubated during only 1 h with the
DOPAC/SNAP and the medium replaced afterwards, cell death still
occurred for later times (not shown). Third, the occurrence of
mitochondrial potential loss (Fig. 5) and ATP decline (Fig. 6) under
conditions of maintenance of membrane integrity (Fig. 3) imparts
biological significance to the experimental model. In connection
with this notion, it is also of note to consider that 50–200mM
DOPAC are required to achieve a higher DOPAC intracellular steady
concentration as PC-12 cells actively secret acidic dopamine
metabolites into the surrounding extracellular medium (Lamens-
dorf et al., 2000b, c). Under our experimental conditions, following
15 min of incubation, a six-fold increase in intracellular DOPAC
C. Nunes et al. / NeuroToxicology 29 (2008) 998–10071006was observed when cells were incubated with NO plus 800 nmol
DOPAC/106 cells (not shown).
In regards to concerns of the physiological significance of high
DOPAC concentrations, one might envisage the following situa-
tion: since Parkinson’s disease is a neurodegenerative disease
associated with aging and chronic oxidative stress is involved in
the aging process, old dopaminergic neurons could become more
susceptible to cell death induced by NO in presence of lower
concentrations of DOPAC.
The synergistic interaction between DOPAC and NO shown
here in promoting cell death may also acquire significance for
Parkinson’s disease under conditions of an increased production of
both, NO and DOPAC, in dopaminergic neurons. In this regard, one
may consider the following notions: (i) the concentration of
DOPAC found in rat cerebrospinal fluid (CSF) obtained from the
third ventricle was c.a. 1.2 mM (Mignot et al., 1984). If one assumes
that a concentration gradient is operative from its local of synthesis
(the mitochondria) and the extracellular fluid, its concentration in
brain mitochondria might be much higher than that in CSF; (ii) an
increased turnover of dopamine (synthesis and metabolism) is
observed in the early stages of Parkinson’s disease (Bernheimer
et al., 1973; Hornykiewicz and Kish, 1996; Strange, 1992). Such a
compensatory mechanism, increasing the cytoplasmic availability
of dopamine, may boost DOPAC concentration due to activated
monoamine oxidase activity (Hastings and Zigmond, 1997; Cubells
et al., 1994; Sulzer et al., 1995); (iii) an increased NO formation in
Parkinson’s disease has been widely suggested (Gerlach et al.,
1999; Hantraye et al., 1996; Itzhak and Ali, 1996; Schulz et al.,
1997).
Therefore, the cell death accompanied by mitochondrial
dysfunction and caspase-independent pathways potentiated by
DOPAC in the presence of NO may be of significance in the
mechanisms of cellular degeneration underlying Parkinson’s
disease.
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